SpecialeAnalysis

Biogen testing channel support

NASDAQ:BIIB   Biogen Inc.
Biogen Inc. (BIIB) currently testing channel support, able to absorb weekly selling pressures.

From here, (BIIB) can recover and turn higher to channel resistance, eliciting gains of 20-25% over the following 2 - 3 months.

A settlement above this week’s high would accelerate this upward momentum.

Inversely, closing below this channel support would indicate losses of 20% over the following 2 - 3 months where (BIIB) can bottom out into Q4.

Anthony Speciale, founder of Speciale Analysis offers an affordable approach for all traders to grow into their highest potential.
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。